Parkinson's disease and systemic inflammation

Parkinson's Disease

Volumn , Issue , 2011, Pages

  Ferrari, Carina C ^a   Tarelli, Rodolfo ^a  

^a FUNDACIÓN INSTITUTO LELOIR   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; CYTOKINE; DEXAMETHASONE; IBUPROFEN; INDOMETACIN; MINOCYCLINE; NONSTEROID ANTIINFLAMMATORY AGENT; ROFECOXIB;

ANTIINFLAMMATORY ACTIVITY; CYTOKINE PRODUCTION; DRUG EFFECT; HUMAN; ILLNESS BEHAVIOR; INFECTION; INFLAMMATION; MICROGLIA; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; SUBSTANTIA NIGRA;

EID: 79955069801     PISSN: None     EISSN: 20420080     Source Type: Journal    
DOI: 10.4061/2011/436813     Document Type: Review

References (117)

1. Kreutzberg G. W., Microglia: a sensor for pathological events in the CNS Trends in Neurosciences 1996 19 8 312 318 (Pubitemid 26349059)
2. Perry V. H., Nicoll J. A. R., Holmes C., Microglia in neurodegenerative disease Nature Reviews Neurology 2010 6 4 193 201
3. Whitton P. S., Inflammation as a causative factor in the aetiology of Parkinson's disease British Journal of Pharmacology 2007 150 8 963 976 (Pubitemid 46628616)
4. Kim S. U., de Vellis J., Microglia in health and disease Journal of Neuroscience Research 2005 81 3 302 313 (Pubitemid 41359284)
5. Ransohoff R. M., Perry V. H., Microglial physiology: unique stimuli, specialized responses Annual Review of Immunology 2009 27 119 145
6. Perry V. H., Cunningham C., Boche D., Atypical inflammation in the central nervous system in prion disease Current Opinion in Neurology 2002 15 3 349 354 (Pubitemid 34596901)
7. Depino A. M., Earl C., Kaczmarczyk E., Ferrari C., Besedovsky H., Del Rey A., Pitossi F. J., Oertel W. H., Microglial activation with atypical proinflammatory cytokine expression in a rat model of Parkinson's disease European Journal of Neuroscience 2003 18 10 2731 2742 (Pubitemid 37542126)
8. Cunningham C., Wilcockson D. C., Campion S., Lunnon K., Perry V. H., Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration Journal of Neuroscience 2005 25 40 9275 9284 (Pubitemid 41500836)
9. McColl B. W., Rothwell N. J., Allan S. M., Systemic inflammatory stimulus potentiates the acute phase and CXC chemokine responses to experimental stroke and exacerbates brain damage via interleukin-1- and neutrophil-dependent mechanisms Journal of Neuroscience 2007 27 16 4403 4412 (Pubitemid 46640725)
10. Arimoto T., Bing G., Up-regulation of inducible nitric oxide synthase in the substantia nigra by lipopolysaccharide causes microglial activation and neurodegeneration Neurobiology of Disease 2003 12 1 35 45 (Pubitemid 36259966)
11. Iravani M. M., Kashefi K., Mander P., Rose S., Jenner P., Involvement of inducible nitric oxide synthase in inflammation-induced dopaminergic neurodegeneration Neuroscience 2002 110 1 49 58 (Pubitemid 34214759)
12. Czlonkowska A., Kurkowska-Jastrzebska I., Czlonkowski A., Peter D., Stefano G. B., Immune processes in the pathogenesis of Parkinson's diseasea potential role for microglia and nitric oxide Medical Science Monitor 2002 8 8 RA165 RA177
13. Minghetti L., Polazzi E., Nicolini A., Greco A., Levi G., Possible role of microglial prostanoids and free radicals in neuroprotection and neurodegeneration Advances in Experimental Medicine and Biology 1999 468 109 119 (Pubitemid 32197925)
14. Dilger R. N., Johnson R. W., Aging, microglial cell priming, and the discordant central inflammatory response to signals from the peripheral immune system Journal of Leukocyte Biology 2008 84 4 932 939
15. Henry C. J., Huang Y., Wynne A. M., Godbout J. P., Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1 and anti-inflammatory IL-10 cytokines Brain, Behavior, and Immunity 2009 23 3 309 317
16. Stolp H. B., Dziegielewska K. M., Review: role of developmental inflammation and blood-brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases Neuropathology and Applied Neurobiology 2009 35 2 132 146
17. Besedovsky H. O., del Rey A., Immune-neuro-endocrine interactions: facts and hypotheses Endocrine Reviews 1996 17 1 64 102 (Pubitemid 26061368)
18. Pitossi F., del Rey A., Kabiersch A., Besedovsky H., Induction of cytokine transcripts in the central nervous system and pituitary following peripheral administration of endotoxin to mice Journal of Neuroscience Research 1997 48 4 287 298 (Pubitemid 27232703)
19. Combrinck M. I., Perry V. H., Cunningham C., Peripheral infection evokes exaggerated sickness behaviour in pre-clinical murine prion disease Neuroscience 2002 112 1 7 11 (Pubitemid 34603493)
20. Perry V. H., The influence of systemic inflammation on inflammation in the brain: implications for chronic neurodegenerative disease Brain, Behavior, and Immunity 2004 18 5 407 413 (Pubitemid 38950834)
21. Londono D., Cadavid D., Bacterial lipoproteins can disseminate from the periphery to inflame the brain American Journal of Pathology 2010 176 6 2848 2857
22. Cunningham C., Wilcockson D. C., Boche D., Perry V. H., Comparison of inflammatory and acute-phase responses in the brain and peripheral organs of the ME7 model of prion disease Journal of Virology 2005 79 8 5174 5184 (Pubitemid 40464266)
23. McColl B. W., Rothwell N. J., Allan S. M., Systemic inflammation alters the kinetics of cerebrovascular tight junction disruption after experimental stroke in mice Journal of Neuroscience 2008 28 38 9451 9462
24. Spencer S. J., Mouihate A., Pittman Q. J., Peripheral inflammation exacerbates damage after global ischemia independently of temperature and acute brain inflammation Stroke 2007 38 5 1570 1577 (Pubitemid 46684176)
25. Perry V. H., Cunningham C., Holmes C., Systemic infections and inflammation affect chronic neurodegeneration Nature Reviews Immunology 2007 7 2 161 167 (Pubitemid 46174862)
26. Palin K., Cunningham C., Forse P., Perry V. H., Platt N., Systemic inflammation switches the inflammatory cytokine profile in CNS Wallerian degeneration Neurobiology of Disease 2008 30 1 19 29
27. Cunningham C., Campion S., Teeling J., Felton L., Perry V. H., The sickness behaviour and CNS inflammatory mediator profile induced by systemic challenge of mice with synthetic double-stranded RNA (poly I:C) Brain, Behavior, and Immunity 2007 21 4 490 502 (Pubitemid 46528682)
28. Godoy M. C. P., Tarelli R., Ferrari C. C., Sarchi M. I., Pitossi F. J., Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease Brain 2008 131 7 1880 1894 (Pubitemid 351957456)
29. Pott Godoy M. C., Ferrari C. C., Pitossi F. J., Nigral neurodegeneration triggered by striatal AdIL-1 administration can be exacerbated by systemic IL-1 expression Journal of Neuroimmunology 2010 222 1-2 29 39
30. Hasegawa Y., Inagaki T., Sawada M., Suzumura A., Impaired cytokine production by peripheral blood mononuclear cells and monocytes/macrophages in Parkinson's disease Acta Neurologica Scandinavica 2000 101 3 159 164 (Pubitemid 30112295)
31. Beyer M. K., Herlofson K., Arsland D., Larsen J. P., Causes of death in a community-based study of Parkinson's disease Acta Neurologica Scandinavica 2001 103 7 11
32. D'Amelio M., Ragonese P., Morgante L., Reggio A., Callari G., Salemi G., Savettieri G., Long-term survival of Parkinson's disease: a population-based study Journal of Neurology 2006 253 1 33 37 (Pubitemid 43157385)
33. Arai H., Furuya T., Mizuno Y., Mochizuki H., Inflammation and infection in Parkinson's disease Histology and Histopathology 2006 21 46 673 678
34. Godbout J. P., Chen J., Abraham J., Richwine A. F., Berg B. M., Kelley K. W., Johnson R. W., Exaggerated neuroinflammation and sickness behavior in aged mice following activation of the peripheral innate immune system FASEB Journal 2005 19 10 1329 1331 (Pubitemid 41113739)
35. Chen J., Buchanan J. B., Sparkman N. L., Godbout J. P., Freund G. G., Johnson R. W., Neuroinflammation and disruption in working memory in aged mice after acute stimulation of the peripheral innate immune system Brain, Behavior, and Immunity 2008 22 3 301 311 (Pubitemid 351172703)
36. Sawada M., Sawada H., Nagatsu T., Effects of aging on neuroprotective and neurotoxic properties of microglia in neurodegenerative diseases Neurodegenerative Diseases 2008 5 3-4 254 256 (Pubitemid 351347865)
37. Wilcockson D. C., Campbell S. J., Anthony D. C., Perry V. H., The systemic and local acute phase response following acute brain injury Journal of Cerebral Blood Flow and Metabolism 2002 22 3 318 326 (Pubitemid 34203059)
38. Campbell S. J., Hughes P. M., Iredale J. P., Wilcockson D. C., Waters S., Docagne F., Perry V. H., Anthony D. C., CINC-1 is an acute-phase protein induced by focal brain injury causing leukocyte mobilization and liver injury FASEB Journal 2003 17 9 1168 1170
39. Campbell S. J., Deacon R. M. J., Jiang Y., Ferrari C., Pitossi F. J., Anthony D. C., Overexpression of IL-1 by adenoviral-mediated gene transfer in the rat brain causes a prolonged hepatic chemokine response, axonal injury and the suppression of spontaneous behaviour Neurobiology of Disease 2007 27 2 151 163 (Pubitemid 47088977)
40. Campbell S. J., Perry V. H., Pitossi F. J., Butchart A. G., Chertoff M., Waters S., Dempster R., Anthony D. C., Central nervous system injury triggers Hepatic CC and CXC chemokine expression that is associated with leukocyte mobilization and recruitment to both the central nervous system and the liver American Journal of Pathology 2005 166 5 1487 1497 (Pubitemid 40586518)
41. Jiang Y., Deacon R., Anthony D. C., Campbell S. J., Inhibition of peripheral TNF can block the malaise associated with CNS inflammatory diseases Neurobiology of Disease 2008 32 1 125 132
42. D'Mello C., Le T., Swain M. G., Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factora signaling during peripheral organ inflammation Journal of Neuroscience 2009 29 7 2089 2102
43. Zlokovic B. V., The blood-brain barrier in health and chronic neurodegenerative disorders Neuron 2008 57 2 178 201
44. Dantzer R., Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity European Journal of Pharmacology 2004 500 13 399 411 (Pubitemid 39304023)
45. Dantzer R., Kelley K. W., Twenty years of research on cytokine-induced sickness behavior Brain, Behavior, and Immunity 2007 21 2 153 160 (Pubitemid 46038917)
46. Goehler L. E., Erisir A., Gaykema R. P. A., Neural-immune interface in the rat area postrema Neuroscience 2006 140 4 1415 1434 (Pubitemid 43928278)
47. Marques F., Sousa J. C., Coppola G., Geschwind D. H., Sousa N., Palha J. A., Correia-Neves M., The choroid plexus response to a repeated peripheral inflammatory stimulus BMC Neuroscience 2009 10, article 135
48. Bohatschek M., Werner A., Raivich G., Systemic LPS injection leads to granulocyte influx into normal and injured brain: effects of ICAM-1 deficiency Experimental Neurology 2001 172 1 137 152 (Pubitemid 33141161)
49. Kortekaas R., Leenders K. L., van Oostrom J. C. H., Vaalburg W., Bart J., Willemsen A. T. M., Hendrikse N. H., Blood-brain barrier dysfunction in Parkinsonian midbrain in vivo Annals of Neurology 2005 57 2 176 179 (Pubitemid 40179854)
50. Carvey P. M., Zhao C. H., Hendey B., Lum H., Trachtenberg J., Desai B. S., Snyder J., Zhu Y. G., Ling Z. D., 6-hydroxydopamine-induced alterations in blood-brain barrier permeability European Journal of Neuroscience 2005 22 5 1158 1168 (Pubitemid 41395380)
51. Barcia C., Bautista V., Sanchez-Bahillo A., Changes in vascularization in substantia nigra pars compacta of monkeys rendered parkinsonian Journal of Neural Transmission 2005 112 9 1237 1248 (Pubitemid 41215926)
52. Chen H., O'Reilly E. J., Schwarzschild M. A., Ascherio A., Peripheral inflammatory biomarkers and risk of Parkinson's disease American Journal of Epidemiology 2008 167 1 90 95
53. Yan E., Castillo-Melendez M., Nicholls T., Hirst J., Walker D., Cerebrovascular responses in the fetal sheep brain to low-dose endotoxin Pediatric Research 2004 55 5 855 863 (Pubitemid 38520455)
54. Tracey K. J., The inflammatory reflex Nature 2002 420 6917 853 859 (Pubitemid 36019638)
55. Perry V. H., Newman T. A., Cunningham C., The impact of systemic infection on the progression of neurodegenerative disease Nature Reviews Neuroscience 2003 4 2 103 112 (Pubitemid 37271380)
56. Bluthe R. M., Michaud B., Kelley K. W., Dantzer R., Vagotomy blocks behavioural effects of interleukin-1 injected via the intraperitoneal route but not via other systemic routes NeuroReport 1996 7 1517 2823 2827 (Pubitemid 26403068)
57. Bluthe R. M., Michaud B., Kelley K. W., Dantzer R., Vagotomy attenuates behavioural effects of interleukin-1 injected peripherally but not centrally NeuroReport 1996 7 9 1485 1488 (Pubitemid 26281127)
58. Dantzer R., Bluthe R. M., Laye S., Bret-Dibat J. L., Parnet P., Kelley K. W., Cytokines and sickness behavior Annals of the New York Academy of Sciences 1998 840 586 590 (Pubitemid 28302084)
59. Bluthe R. M., Walter V., Parnet P., Laye S., Lestage J., Verrier D., Poole S., Stenning B. E., Kelley K. W., Dantzer R., Lipopolysaccharide induces sickness behaviour in rats by a vagal mediated mechanism Comptes Rendus de l'Academie des Sciences 1994 317 6 499 503 (Pubitemid 24220250)
60. Hansen M. K., Taishi P., Chen Z., Krueger J. M., Vagotomy blocks the induction of interleukin-1 (IL-1 ) mRNA in the brain of rats in response to systemic IL-1 Journal of Neuroscience 1998 18 6 2247 2253 (Pubitemid 28141429)
61. Goehler L. E., Gaykema R. P. A., Nguyen K. T., Lee J. E., Tilders F. J. H., Maier S. F., Watkins L. R., Interleukin-1 in immune cells of the abdominal vagus nerve: a link between the immune and nervous systems? Journal of Neuroscience 1999 19 7 2799 2806 (Pubitemid 29162426)
62. Kamer A. R., Craig R. G., Dasanayake A. P., Brys M., Glodzik-Sobanska L., de Leon M. J., Inflammation and Alzheimer's disease: possible role of periodontal diseases Alzheimer's and Dementia 2008 4 4 242 250 (Pubitemid 351866113)
63. Rostene W., Kitabgi P., Parsadaniantz S. M., Chemokines: a new class of neuromodulator? Nature Reviews Neuroscience 2007 8 11 895 904 (Pubitemid 350006221)
64. Dale R. C., Church A. J., Surtees R. A. H., Lees A. J., Adcock J. E., Harding B., Neville B. G. R., Giovannoni G., Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity Brain 2004 127 1 21 33 (Pubitemid 38055343)
65. Shoji H., Watanabe M., Itoh S., Kuwahara H., Hattori F., Japanese encephalitis and parkinsonism Journal of Neurology 1993 240 1 59 60
66. Jang H., Boltz D., Sturm-Ramirez K., Shepherd K. R., Jiao Y., Webster R., Smeyne R. J., Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration Proceedings of the National Academy of Sciences of the United States of America 2009 106 33 14063 14068
67. Mogi M., Harada M., Kondob T., Riederer P., Inagaki H., Minami M., Nagatsu T., Interleukin-1, interleukin-6, epidermal growth factor and transforming growth factor- are elevated in the brain from parkinsonian patients Neuroscience Letters 1994 180 2 147 150
68. Mogi M., Harada M., Narabayashi H., Inagaki H., Minami M., Nagatsu T., Interleukin (IL)-1, IL-2, IL-4, IL-6 and transforming growth factor- levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease Neuroscience Letters 1996 211 1 13 16 (Pubitemid 26228016)
69. Hirsch E. C., Hunot S., Neuroinflammation in Parkinson's disease: a target for neuroprotection? Lancet Neurology 2009 8 4 382 397
70. Dobbs R. J., Charlett A., Purkiss A. G., Dobbs S. M., Weller C., Peterson D. W., Association of circulating TNF- and IL-6 with ageing and parkinsonism Acta Neurologica Scandinavica 1999 100 1 34 41 (Pubitemid 29292549)
71. Blum-Degena D., Muller T., Kuhn W., Gerlach M., Przuntek H., Riederer P., Interleukin-1 and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients Neuroscience Letters 1995 202 1-2 17 20
72. Reale M., Iarlori C., Thomas A., Gambi D., Perfetti B., Di Nicola M., Onofrj M., Peripheral cytokines profile in Parkinson's disease Brain, Behavior, and Immunity 2009 23 1 55 63
73. Hisanaga K., Asagi M., Itoyama Y., Iwasaki Y., Increase in peripheral CD4 bright+ CD8 dull+T cells in Parkinson disease Archives of Neurology 2001 58 10 1580 1583 (Pubitemid 32963221)
74. Bas J., Calopa M., Mestre M., Lymphocyte populations in Parkinson's disease and in rat models of parkinsonism Journal of Neuroimmunology 2001 113 1 146 152 (Pubitemid 32008680)
75. Tansey M. G., McCoy M. K., Frank-Cannon T. C., Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention Experimental Neurology 2007 208 1 1 25 (Pubitemid 47603240)
76. Frank-Cannon T. C., Alto L. T., McAlpine F. E., Tansey M. G., Does neuroinflammation fan the flame in neurodegenerative diseases? Molecular Neurodegeneration 2009 4 1, article 47
77. Chung Y. C., Ko H. W., Bok E., Park E. S., Huh S. H., Nam J. H., Jin B. K., The role of neuroinflammation on the pathogenesis of Parkinson's disease BMB Reports 2010 43 4 225 232
78. Esposito E., Di Matteo V., Benigno A., Pierucci M., Crescimanno G., Di Giovanni G., Non-steroidal anti-inflammatory drugs in Parkinson's disease Experimental Neurology 2007 205 2 295 312 (Pubitemid 46778915)
79. Koprich J. B., Reske-Nielsen C., Mithal P., Isacson O., Neuroinflammation mediated by IL-1 increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson's disease Journal of Neuroinflammation 2008 5, article 8
80. Wahner A. D., Sinsheimer J. S., Bronstein J. M., Ritz B., Inflammatory cytokine gene polymorphisms and increased risk of Parkinson disease Archives of Neurology 2007 64 6 836 840 (Pubitemid 46919838)
81. Scalzo P., Kummer A., Cardoso F., Teixeira A. L., Increased serum levels of soluble tumor necrosis factor- receptor-1 in patients with Parkinson's disease Journal of Neuroimmunology 2009 216 1-2 122 125
82. Dufek M., Hamanova M., Lokaj J., Serum inflammatory biomarkers in Parkinson's disease Parkinsonism and Related Disorders 2009 15 4 318 320
83. Hamza T. H., Zabetian C. P., Tenesa A., Laederach A., Montimurro J., Yearout D., Kay D. M., Doheny K. F., Paschall J., Pugh E., Kusel V. I., Collura R., Roberts J., Griffith A., Samii A., Scott W. K., Nutt J., Factor S. A., Payami H., Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease Nature Genetics 2010 42 9 781 785
84. Przuntek H., Muller T., Riederer P., Diagnostic staging of Parkinson's disease: conceptual aspects Journal of Neural Transmission 2004 111 2 201 216 (Pubitemid 38283231)
85. Weller C., Oxlade N., Dobbs S. M., Dobbs R. J., Charlett A., Bjarnason I. T., Role of inflammation in gastrointestinal tract in aetiology and pathogenesis of idiopathic parkinsonism FEMS Immunology and Medical Microbiology 2005 44 2 129 135 (Pubitemid 41378983)
86. Baba Y., Kuroiwa A., Uitti R. J., Wszolek Z. K., Yamada T., Alterations of T-lymphocyte populations in Parkinson disease Parkinsonism and Related Disorders 2005 11 8 493 498 (Pubitemid 41627840)
87. Akiyama H., Itagaki S., McGeer P. L., Major histocompatibility complex antigen expression on rat microglia following epidural kainic acid lesions Journal of Neuroscience Research 1988 20 147 157
88. Brochard V., Combadiere B., Prigent A., Laouar Y., Perrin A., Beray-Berthat V., Bonduelle O., Alvarez-Fischer D., Callebert J., Launay J. M., Duyckaerts C., Flavell R. A., Hirsch E. C., Hunot S., Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease Journal of Clinical Investigation 2009 119 1 182 192
89. Stone D. K., Reynolds A. D., Mosley R. L., Gendelman H. E., Innate and adaptive immunity for the pathobiology of Parkinson's disease Antioxidants and Redox Signaling 2009 11 9 2151 2166
90. Tansey M. G., Goldberg M. S., Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention Neurobiology of Disease 2010 37 3 510 518
91. Chen H., Zhang S. M., Hernan M. A., Schwarzschild M. A., Willett W. C., Colditz G. A., Speizer F. E., Ascherio A., Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease Archives of Neurology 2003 60 8 1059 1064 (Pubitemid 36975791)
92. Chen H., Jacobs E., Schwarzschild M. A., McCullough M. L., Calle E. E., Thun M. J., Ascherio A., Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease Annals of Neurology 2005 58 6 963 967 (Pubitemid 41746889)
93. Tikka T. M., Koistinaho J. E., Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia Journal of Immunology 2001 166 12 7527 7533 (Pubitemid 32525632)
94. Kim H. S., Suh Y. H., Minocycline and neurodegenerative diseases Behavioural Brain Research 2009 196 2 168 179
95. Tomas-Camardiel M., Rite I., Herrera A. J., De Pablos R. M., Cano J., Machado A., Venero J. L., Minocycline reduces the lipopolysaccharide-induced inflammatory reaction, peroxynitrite-mediated nitration of proteins, disruption of the blood-brain barrier, and damage in the nigral dopaminergic system Neurobiology of Disease 2004 16 1 190 201 (Pubitemid 38569810)
96. Kosloski L. M., Ha D. M., Hutter J. A. L., Stone D. K., Pichler M. R., Reynolds A. D., Gendelman H. E., Mosley R. L., Adaptive immune regulation of glial homeostasis as an immunization strategy for neurodegenerative diseases Journal of Neurochemistry 2010 114 5 1261 1276
97. Kluger M. J., Fever: role of pyrogens and cryogens Physiological Reviews 1991 71 1 93 127
98. Carvey P. M., Chang Q., Lipton J. W., Ling Z., Prenatal exposure to the bacteriotoxin lipopolysaccharide leads to long-term losses of dopamine neurons in offspring: a potential, new model of Parkinson's disease Frontiers in Bioscience 2003 8 s826 s837
99. Ling Z. D., Gayle D. A., Ma S. Y., Lipton J. W., Tong C. W., Hong J. S., Carvey P. M., In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain Movement Disorders 2002 17 1 116 124 (Pubitemid 36041267)
100. Ling Z., Chang Q. A., Tong C. W., Leurgans S. E., Lipton J. W., Carvey P. M., Rotenone potentiates dopamine neuron loss in animals exposed to lipopolysaccharide prenatally Experimental Neurology 2004 190 2 373 383 (Pubitemid 39504993)
101. Engler H., Doenlen R., Riether C., Engler A., Niemi M. -B., Besedovsky H. O., Rey A. d., Pacheco-Lpez G., Feldon J., Schedlowski M., Time-dependent alterations of peripheral immune parameters after nigrostriatal dopamine depletion in a rat model of Parkinson's disease Brain, Behavior, and Immunity 2009 23 4 518 526
102. Villarn R. F., Espinosa-Oliva A. M., Sarmiento M., De Pablos R. M., Argelles S., Delgado-Corts M. J., Sobrino V., Van Rooijen N., Venero J. L., Herrera A. J., Cano J., MacHado A., Ulcerative colitis exacerbates lipopolysaccharide-induced damage to the nigral dopaminergic system: potential risk factor in Parkinson's disease Journal of Neurochemistry 2010 114 6 1687 1700
103. Anthony D. C., Bolton S. J., Fearn S., Perry V. H., Age-related effects of interleukin-1 on polymorphonuclear neutrophil-dependent increases in blood-brain barrier permeability in rats Brain 1997 120 3 435 444 (Pubitemid 27153636)
104. Ferrari C. C., Depino A. M., Prada F., Muraro N., Campbell S., Podhajcer O., Perry V. H., Anthony D. C., Pitossi F. J., Reversible demyelination, blood-brain barrier breakdown, and pronounced neutrophil recruitment induced by chronic IL-1 expression in the brain American Journal of Pathology 2004 165 5 1827 1837 (Pubitemid 39435180)
105. Ferrari C. C., Pott Godoy M. C., Tarelli R., Chertoff M., Depino A. M., Pitossi F. J., Progressive neurodegeneration and motor disabilities induced by chronic expression of IL-1 in the substantia nigra Neurobiology of Disease 2006 24 1 183 193 (Pubitemid 44437611)
106. Shaftel S. S., Carlson T. J., Olschowka J. A., Kyrkanides S., Matousek S. B., O'Banion M. K., Chronic interleukin-1 expression in mouse brain leads to leukocyte infiltration and neutrophil-independent blood-brain barrier permeability without overt neurodegeneration Journal of Neuroscience 2007 27 35 9301 9309 (Pubitemid 47358197)
107. Campbell S. J., Wilcockson D. C., Butchart A. G., Perry V. H., Anthony D. C., Altered chemokine expression in the spinal cord and brain contributes to differential interleukin-1 -induced neutrophil recruitment Journal of Neurochemistry 2002 83 2 432 441 (Pubitemid 35191408)
108. Ching S., He L., Lai W., Quan N., IL-1 type I receptor plays a key role in mediating the recruitment of leukocytes into the central nervous system Brain, Behavior, and Immunity 2005 19 2 127 137 (Pubitemid 40138647)
109. Qin L., Wu X., Block M. L., Liu Y., Breese G. R., Hong J. S., Knapp D. J., Crews F. T., Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration GLIA 2007 55 5 453 462 (Pubitemid 46383175)
110. McCoy M. K., Martinez T. N., Ruhn K. A., Szymkowski D. E., Smith C. G., Botterman B. R., Tansey K. E., Tansey M. G., Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease Journal of Neuroscience 2006 26 37 9365 9375 (Pubitemid 44396849)
111. Reynolds A. D., Banerjee R., Liu J., Gendelman H. E., Mosley R. L., Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson's disease Journal of Leukocyte Biology 2007 82 5 1083 1094 (Pubitemid 350133504)
112. Reynolds A. D., Stone D. K., Hutter J. A. L., Benner E. J., Mosley R. L., Gendelman H. E., Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson's disease Journal of Immunology 2010 184 5 2261 2271
113. Huang X., Reynolds A. D., Mosley R. L., Gendelman H. E., CD 4+ T cells in the pathobiology of neurodegenerative disorders Journal of Neuroimmunology 2009 211 1-2 3 15
114. Kurkowska-Jastrzebska I., Babiuch M., Joniec I., Przybylkowski A., Czlonkowski A., Czlonkowska A., Indomethacin protects against neurodegeneration caused by MPTP intoxication in mice International Immunopharmacology 2002 2 8 1213 1218
115. Teismann P., Tieu K., Choi D. K., Wu DU. C., Naini A., Hunot S., Vila M., Jackson-Lewis V., Przedborski S., Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration Proceedings of the National Academy of Sciences of the United States of America 2003 100 9 5473 5478 (Pubitemid 36542729)
116. Teismann P., Vila M., Choi D. K., Tieu K., Wu D. C., Jackson-Lewis V., Przedborski S., COX-2 and neurodegeneration in Parkinson's disease Annals of the New York Academy of Sciences 2003 991 272 277 (Pubitemid 36793820)
117. Sanchez-Pernaute R., Ferree A., Cooper O., Yu M., Brownell A. L., Isacson O., Selective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat model of Parkinson's disease Journal of Neuroinflammation 2004 1, article 6